4
Changes in Ownership
HALOZYME THERAPEUTICS, INC. Filed Acc 0001179110-21-007391
SVP, Chief Technical Officer sold 40,315 shares at $45.70 ($1,842,315)
- SVP, Chief Technical Officer acquired 40,315 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
LaBarre Michael J. · SVP, Chief Technical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-07-01 | Exercise or conversion : show line 1 in the form | +40,315 | $6.55 | $264,063 | 174,426 | D |
| 2021-07-01 | Sale : show line 2 in the form | −40,315 | $45.70 | $1,842,315 | 134,111 | D |
| Open-market sales · 40,315 sh · avg $45.70 · $1,842,315 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2021-07-01 | Exercise or conversion : show line 3 in the form Option to Purchase Common Stock | −40,315 | $6.55 | 2023-02-04 | 40,315 | 14,685 | D |
Loading xslF345X03/edgar.xml…